Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
We focus on organic and wild-crafted sourcing whenever possible
The published research literature has investigated: GHRH receptor activation in pituitary somatotroph cells Pulsatile release of endogenous growth hormone Subsequent IGF-1 elevation through downstream GH signaling Maintained natural feedback regulation through somatostatin and IGF-1 DPP-4-resistant pharmacokinetics from the trans-3-hexenoic acid modification The two compounds produce fundamentally different research effects: AOD-9604 produces lipolytic activity without affecting IGF-1 or broader GH-mediated signaling Tesamorelin produces full GH axis activation including IGF-1 elevation and broader GH-mediated effects Pharmacokinetic Comparison The compounds have different pharmacokinetic profiles: AOD-9604
t 1/2 , half-life
This is because its a naturally occurring peptide produced in the body
What works for some patients, may be ineffective for others
